Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

X

XLO

Xilio Therapeutics Inc

9.49

Aug 17 • 3:59 PM ET +0.32 (3.49%)

9.45

Aftermarket • 4:15 PM ET -0.04 (-0.42%)

Healthcare Biotechnology USA Micro NASD

Peers: RADX RNTX TELO GLSI INDP OTLK TARA PALI PRLD RZLT

| Held by: VTI VXF IWC DCOR DFAC

Scroll to Statements

Index	-
Market Cap	62.45M
Enterprise Value	-67.29M
Income	-21.83M
Sales	64.09M
Book/sh	10.98
Cash/sh	20.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	76
IPO	Oct 22, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	0.97
P/B	0.86
P/C	0.46
P/FCF	-
EV/EBITDA	-
EV/Sales	-1.05
Quick Ratio	4.25
Current Ratio	4.25
Debt/Eq	0.09
LT Debt/Eq	0.07
Option/Short	No / Yes

EPS (ttm)	-1.69
EPS next Y	-2.23
EPS next Q	-0.82
EPS this Y	38.19%
EPS next Y	13.90%
EPS next 5Y	8.69%
EPS past 3/5Y	54.70% 31.67%
Sales past 3/5Y	- -
EPS Y/Y TTM	85.65%
Sales Y/Y TTM	327.25%
EPS Q/Q	85.72%
Sales Q/Q	131.22%
Earnings	Aug 12 BMO
EPS/Sales Surpr.	44.07% 46.95%

Insider Own	53.64%
Insider Trans	0.14%
Inst Own	24.11%
Inst Trans	-3.46%
ROA	-15.16%
ROE	-55.03%
ROIC	-28.30%
Gross Margin	97.91%
Oper. Margin	-48.94%
Profit Margin	-34.06%
SMA20	5.18%
SMA50	6.80%
SMA200	7.44%
Trades

Shs Outstand	6.58M
Shs Float	3.05M
Short Float	13.96%
Short Ratio	12.05
Short Interest	0.43M
52W High	12.74 -25.50%
52W Low	6.47 46.79%
Volatility	5.34% 5.13%
ATR (14)	0.45
RSI (14)	62.91
Beta	-0.11
Rel Volume	1.32
Avg Volume	35.34K
Volume	46,493

Perf Week	3.15%
Perf Month	6.87%
Perf Quarter	13.52%
Perf Half Y	16.83%
Perf YTD	5.88%
Perf Year	-4.39%
Perf 3Y	-74.80%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	20.00
Prev Close	9.17
Price	9.49
Change %	3.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)